Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
6(50%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
10
83%
Ph phase_2
2
17%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
2(16.7%)
N/ANon-phased studies
10(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

6

trials recruiting

Total Trials

12

all time

Status Distribution
Active(7)
Completed(4)
Other(1)

Detailed Status

Completed4
Active, not recruiting3
Recruiting3
unknown1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
6
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (16.7%)
N/A10 (83.3%)

Trials by Status

active_not_recruiting325%
completed433%
recruiting325%
unknown18%
enrolling_by_invitation18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12